TAVR and more on tap for SCAI 2013 LBCTs

04/22/2013 | CardiovascularBusiness.com

Late-breaking clinical trials to be featured at the SCAI 2013 Scientific Sessions include an assessment of transcatheter aortic valve replacement with procedure transmission, a trial evaluating hydration protocols to prevent contrast medium-induced nephropathy and a study looking at outcomes of angioplasty following carotid stent placement. The annual conference will also offer a symposium on congenital heart disease; coronary, peripheral and structural tracks; and many other sessions.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park